InvestorsHub Logo
Followers 107
Posts 4236
Boards Moderated 0
Alias Born 03/16/2017

Re: None

Friday, 01/18/2019 12:27:19 PM

Friday, January 18, 2019 12:27:19 PM

Post# of 35961
Too much going on here with Inspyr:
1. $12 Million from licensing on Adenosine receptors
2. Such a low floater 150M AS
3. Inspyr's lead product candidate Mipsagargin (Orphan Drug designation), completed Phase II with good results, already spent $50 million.
4. And now JLL ($6.52B) with controlling interest in Inspyr
5. Filings coming to get current

Market cap currently valued at $400,000 USD

Wow...just wow...$_$

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News